In vivo effects of putative crowding factors on development of Hymenolepis diminuta.
During in vitro incubation, Hymenolepsis diminuta secretes substances into the medium that inhibit DNA synthesis in the germinative region of freshly isolated, uncrowded worms. Of the many substances that are released by H. diminuta into the medium, earlier studies indicate that only succinate, acetate, glucosaminic acid, and cGMP are responsible for the inhibition. In the present report, effects of these putative crowding factors on worm development in vivo were examined. At 7 days postinfection the proximal end of the host's intestine was catheterized and perfused with test solution. The test solution contained 28 nM cGMP, 250 microM glucosaminic acid, 120 mM succinate, and 40 mM acetate. The solution was perfused by a peristaltic pump at a rate of 50 ml/day. At 2 wk postinfection, worms were recovered for subsequent analysis. Worms developing in the presence of crowding factors were 53% less in wet weight than control worms. Carbohydrate concentrations in worms from experimental groups were not different from those in control groups; therefore, the inhibition in growth was probably not due to carbohydrate deprivation. Worms from experimental groups had fewer immature, mature, and gravid proglottids than did worms from control groups. The results are consistent with the hypothesis that the tested substances, which inhibit DNA synthesis in H. diminuta in vitro, are a part of the cause of the crowding effect in vivo.
Cook
R L
RL
Department of Biological Sciences, Texas Tech University, Lubbock 79409.
Roberts
L S
LS
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D050260:Carbohydrate Metabolism; D002241:Carbohydrates / Q000032:analysis; D006152:Cyclic GMP / Q000494:pharmacology; D005260:Female; D005944:Glucosamine / Q000031:analogs & derivatives / Q000494:pharmacology; D006925:Hymenolepiasis / Q000469:parasitology*; D006926:Hymenolepis / Q000187:drug effects / Q000254:growth & development*; D051381:Rats; D013386:Succinates / Q000494:pharmacology; D015430:Weight Gain
D000085:Acetates; D002241:Carbohydrates; D013386:Succinates; C035547:glucosaminic acid; D006152:Cyclic GMP; D005944:Glucosamine